ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

The Outcome of 0 Mismatch Kidney in Pediatric Population with High Immunologic. The Impact of Induction Therapy. An Analysis of UNOS Database.

V. Whittaker, M. Laftavi, Z. Acun, R. Gruessner, A. Gruessner.

Surgery, State University New York, Syracuse, NY

Meeting: 2017 American Transplant Congress

Abstract number: D173

Keywords: HLA matching, Induction therapy, Outcome, Pediatric

Session Information

Date: Tuesday, May 2, 2017

Session Name: Poster Session D: Kidney: Pediatric

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Related Abstracts
  • Outcome of Living Donor Transplantation in Pediatric Recipients Over the Last Three Decades by Era: An Analysis of UNOS Database.
  • Do Induction Therapy, Patient-Level and Post-Operative Factors Impact Outcomes in Moderate to High Immunologic Risk Simultaneous Kidney-Pancreas Transplantation in the Era of Stringent HLA Cross-Matching?

Background: 0 mismatch kidneys have superior outcomes in primary transplant recipient. We performed Analysis UNOS database to determine the outcome of high PRA transplant pediatric recipients.

Methods: Retrospective Analysis of UNOS database 2008-2015 pediatric recipients receiving 0 mismatch kidneys. Chi Squared analysis of outcome based on Induction, maintainance immunosuppression, donor type, race, years of transplant, donor age, recipient age, cold ischemic time, cPRA and maintainance immunosuppression. Analysis stratified based on donor types. Life test procedures conducted to evaluate graft and patient survival in living and cadaveric donors based on induction therapy. PRA > 20 was used as the cut off for high risk.

Results:

Total of 47 recipients:25 Cadaveric, 8 Living. The median age 13 years, median donor age 29 years. There were 68% cadaveric, 55% male. Of the cadaveric donors 78.1% White, 6.3% Blacks, Hispanic 12.5%, Other 3.1% Among living donors 53.3% were White, 20% Blacks, Hispanic 20%, Asian 6.7%. With increasing years since 2008, there were no change in trends of 0 mismatch donors being transplanted. 25% were primary, secondary 31%, tertiary transplants accounted for 8.5% of all this cohort. DCD 0%. For Cadaveric the median cold ischemic time 21 hours, and median cPRA 87%. For Living donors: the median cold ischemic time 1 hours, and median cPRA 72% Induction: For cadaveric organs- depleting antibodies 65.6%, non-depleting 9.4%, No induction 21.9% and Combined depleting and non-depleting agent 3.1%. For maintenance MMF was used in 89.4% of recipients and Tacrolimus in 93.6%. Immunosuppression in cadaveric donors: Tac/MMF/Steroid 46.9%, Tac/MMF 40.6 and 43.6 % steroid free. For Living donors: Tac/MMF/Steroid 53.3%, Tac/MMF 40%, steroid free 40%. In Cadaveric donors Graft survival was not statistically different based on Induction therapy with p value 0.4795. In living donor graft survival was unaffected by induction therapy and excellent whether it was used or not. Patient survival showed no statistical difference by induction in cadaveric group or living donor group and was excellent 90-100% at 4 years.

Conclusion: Cadaveric donors graft and patient survival as well as living donor graft and patient survival is not statistically different based on induction therapy. Less induction is safe and feasible in 0 mismatch transplant recipients at high immunologic risk in the pediatric age group.

CITATION INFORMATION: Whittaker V, Laftavi M, Acun Z, Gruessner R, Gruessner A. The Outcome of 0 Mismatch Kidney in Pediatric Population with High Immunologic. The Impact of Induction Therapy. An Analysis of UNOS Database. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Whittaker V, Laftavi M, Acun Z, Gruessner R, Gruessner A. The Outcome of 0 Mismatch Kidney in Pediatric Population with High Immunologic. The Impact of Induction Therapy. An Analysis of UNOS Database. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/the-outcome-of-0-mismatch-kidney-in-pediatric-population-with-high-immunologic-the-impact-of-induction-therapy-an-analysis-of-unos-database/. Accessed February 27, 2021.

« Back to 2017 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.